Vet company Greencross shares leap despite net profit down

Company News

by Rachael Jones

Vet and pet care specialist Greencross (ASX:GXL) has seen a dip in full-year net profit as a result of writedowns but underlying sales have improved.

Underlying EBITDA is $97.6 million – that’s in line with guidance.

Statutory NPAT of $20.7 million.

EBITDA attributable to the owners of Greencross is down 25 per cent $74.8 million from $99.8 million.

Final fully franked dividend of 5.5 cents per share.

Shares in Greencross (ASX:GXL) is up 5.79 per cent to $4.48